NASDAQ : ICLR
ICON Public Limited Company — Key statistics
Healthcare · Diagnostics & Research · Ireland
Last price 211.36 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 15.83B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 15.37B |
| Enterprise Value | 18.07B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 74.92M |
| Shares Outstanding | 74.92M |
| Shares Change (YoY) | -3.44% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 109.87% |
| Float | 74.86M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 36.67 |
| Forward PE | 18.18 |
| PS Ratio | 1.87 |
| Forward PS | 1.84 |
| PB Ratio | 1.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.31 |
| P/OCF Ratio | 14.36 |
| PEG Ratio | 3.23 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.67 |
| EV / Sales | 2.19 |
| EV / EBITDA | 37.11 |
| EV / EBIT | 80.72 |
| EV / FCF | 18.00 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.32 |
| Quick Ratio | 1.27 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 6.58 |
| Debt / FCF | 3.50 |
| Interest Coverage | 1.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 4.69% |
| Return on Assets (ROA) | 0.85% |
| Return on Invested Capital (ROIC) | 1.59% |
| Return on Capital Employed (ROCE) | 1.66% |
| Weighted Average Cost of Capital (WACC) | 9.95% |
| Revenue Per Employee | $204,845 |
| Profits Per Employee | $10,780 |
| Employee Count | 40,200 |
| Asset Turnover | 0.50 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 78.88M |
| Effective Tax Rate | 15.40% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +19.39% |
| 50-Day Moving Average | 172.63 |
| 200-Day Moving Average | 145.92 |
| Relative Strength Index (RSI) | 67.40 |
| Average Volume (20 Days) | 1,162,083 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.97M |
| Short Previous Month | 2.80M |
| Short % of Shares Out | 4.50% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.06 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 8.23B |
| Gross Profit | 1.93B |
| Operating Income | 223.73M |
| Pretax Income | 512.23M |
| Net Income | 433.36M |
| EBITDA | 486.65M |
| EBIT | 223.73M |
| Earnings Per Share (EPS) | $5.59 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 808.98M |
| Total Debt | 3.51B |
| Net Cash | -2.70B |
| Net Cash Per Share | -$36.04 |
| Equity (Book Value) | 9.13B |
| Book Value Per Share | 121.83 |
| Working Capital | 872.72M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.07B |
| Capital Expenditures | -66.09M |
| Depreciation & Amortization | 262.92M |
| Net Borrowing | -66.12M |
| Free Cash Flow | 1.00B |
| FCF Per Share | $13.39 |
Margins
| Measure | Value |
|---|
| Gross Margin | 23.44% |
| Operating Margin | 2.72% |
| Pretax Margin | 6.22% |
| Profit Margin | 5.26% |
| EBITDA Margin | 5.91% |
| EBIT Margin | 2.72% |
| FCF Margin | 12.19% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.44% |
| Shareholder Yield | 3.44% |
| Earnings Yield | 2.73% |
| FCF Yield | 6.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $231.29 |
| Price Target Difference | 12.75% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 3.25% |
| EPS Growth Forecast (3Y) | 1.76% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 13, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |